C4 Therapeutics's total assets for Q2 2024 were $376.06M, a decrease of -1.32% from the previous quarter. CCCC total liabilities were $133.40M for the fiscal quarter, a -0.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.